Cash-strapped Novan takes a hard knock as molluscum drug fizzles in late-stage trials
Tiny Novan is not just low on funds, its investors are also scraping the barrel for some confidence.
The Morrisville, North Carolina-based drug developer’s stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
